Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117393) titled 'Zinc Efficacy in Bilirubin Reduction and Assessment in Term Neonates' on Sept. 10.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Investigator Blinded
Primary Sponsor: Amit Kumar
Condition:
Health Condition 1: P599- Neonatal jaundice, unspecified
Intervention:
Intervention1: Oral Zinc 20mg per 5 ml: 1.25 ml equivalent to 5 mg Zinc per Oral once daily for 3 cons...